Information was received from a health care provider (hcp) and consumer regarding a patient who was implanted with a neurostimulator for spinal pain.It was noted that the patient¿s medical history includes diabetes.A diabetic insulin pump was noted to be in use and had been used prior to scs implant.It was reported that the patient was still in the hospital after implant.The implant occurred on (b)(6) 2017.¿something happened¿ and the patient got really sick.The patient went into diabetic ketoacidosis and became dehydrated.It was confirmed that prior to the ins implant, the patient had diabetes and an implanted insulin pump.It was requested that a manufacturer representative program the patient¿s implantable neurostimulator (ins).The patient could not find that card that they were given by the manufacturer representative.Additional information was received from the hcp on (b)(6) 2017 reporting that the implant was not the cause of the patient¿s admission to the hospital.The patient was a brittle diabetic and had a reaction to steroids given in the emergency room for their pain.The steroids started the patient¿s problem with an increase of blood sugar.The implant was reported to be stable and was not the source.It again was clarified that the cause of the issue was the patient¿s pain control and not the stimulator.Actions taken that resolved the diabetic ketoacidosis, dehydration, and sickness were admission to medicine service, insulin, and dietary restriction.Patient weight was provided.No further complications were reported.
|